Transaction in Own Shares

    Transaction in Own Shares
             
Novo Nordisk A/S - Share repurchase programme


On 15 August 2008 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an
amount of up to DKK 1.7 billion in the period from 15 August 2008 to
19 December 2008.

Since the announcement as of 17 November 2008, the following
transactions have been made under the programme:


                  Number of    Average      Transaction
                   shares   purchase price  value, DKK
Accumulated, last
announcement      3,626,500                1,032,250,004
17 November 2008     50,000    295.7000       14,785,000
18 November 2008     50,000    287.9700       14,398,500
19 November 2008     50,000    284.8000       14,240,000
20 November 2008     75,000    287.2300       21,542,250
21 November 2008    100,000    275.1500       27,515,000
Accumulated under
the programme     3,951,500                1,124,730,754


With the transactions stated above, Novo Nordisk owns a total of
24,918,285 treasury shares, corresponding to 3.9% of the share
capital. The total amount of shares in the company is 634,000,000
including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes
care. In addition, Novo Nordisk has a leading position within areas
such as haemostasis management, growth hormone therapy and hormone
replacement therapy. Novo Nordisk manufactures and markets
pharmaceutical products and services that make a significant
difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs approximately 26,550
employees in 80 countries, and markets its products in 179 countries.
Novo Nordisk's B shares are listed on the stock exchanges in
Copenhagen and London. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.

Further information:

Media:                 Investors:

Outside North America  Mads Veggerby Lausten
Elin K Hansen          Tel: [phone]
Tel: [phone]   [e-mail]
[e-mail]
                       Hans Rommer
In North America:      Tel: [phone]
Sean Clements          [e-mail]
Tel: [phone]
[e-mail]   Kasper Roseeuw Poulsen
                       Tel: [phone]
                       [e-mail]


Company Announcement no 77 / 2008

http://hugin.info/2013/R/1272517/282513.pdf


This announcement was originally distributed by Hugin. The issuer is 
solely responsible for the content of this announcement.